Clinical Trial Update: Combined HCC-MFCCC

View source ↗

Summary

This clinical trial update indicates the Combined HCC-MFCCC study sponsored by the University of Milan has completed its trial. The conditions involved include …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Hepatocellular Carcinoma

Snippet

Sponsor: University of Milan | Conditions: Liver Carcinoma, Hepatocellular Carcinoma | Status: COMPLETED